The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis

INTRODUCTION: Multidrug-resistant tuberculosis (MDR-TB) is a hard-to-treat disease with a poor outcome of chemotherapy. In the present study, the efficacy and safety of recombinant human interleukin-2 (rhIL-2) were investigated in patients with MDR-TB. MATERIAL AND METHODS: Fifty culture-confirmed p...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Hong, Min, Rui, Tan, Qi, Xie, Weiping, Wang, Hong, Pan, Hongqiu, Zhang, Li, Xu, Hongtao, Zhang, Xia, Dai, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495154/
https://www.ncbi.nlm.nih.gov/pubmed/26170852
http://dx.doi.org/10.5114/aoms.2015.52362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495154/
https://www.ncbi.nlm.nih.gov/pubmed/26170852
http://dx.doi.org/10.5114/aoms.2015.52362

Ejemplares similares